Develops next-generation immunotherapies and vaccines to strengthen the immune system, targeting cancer and infectious diseases with innovative, personalized treatments.
Notice Date
June 11, 2025
—
July 29, 2025
August 12, 2025
Woburn
Massachusetts
Boston
